Antibody treatment to deplete transthyretin amyloid deposits in the heart
- PMID: 37286706
- DOI: 10.1038/s41569-023-00899-7
Antibody treatment to deplete transthyretin amyloid deposits in the heart
Comment on
-
Phase 1 Trial of Antibody NI006 for Depletion of Cardiac Transthyretin Amyloid.N Engl J Med. 2023 Jul 20;389(3):239-250. doi: 10.1056/NEJMoa2303765. Epub 2023 May 20. N Engl J Med. 2023. PMID: 37212440 Clinical Trial.
References
Original article
-
- Garcia-Pavia, P. et al. Phase 1 trial of antibody NI006 for depletion of cardiac transthyretin amyloid. N. Engl. J. Med. https://doi.org/10.1056/NEJMoa2303765 (2023) - DOI - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials